← Back to Search

Donor milk for Breastfeeding (MGM Trial)

N/A
Waitlist Available
Led By Valerie Flaherman, MD, MPH
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Late preterm newborns >=34 weeks and <37 weeks gestation
Breastfeeding
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week and 1 month after enrollment
Awards & highlights

MGM Trial Summary

This trial will compare banked donor milk to formula for breastfeeding late preterm infants born in San Francisco to assess growth and impacts on the type of bacteria in the baby's intestine.

Eligible Conditions
  • Premature Baby
  • Growth Delay
  • Microbial Colonization
  • Breastfeeding
  • Breast Milk Substitute Intolerance

MGM Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

MGM Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week and 1 month after enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 week and 1 month after enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Bifidobacteria
Clostridium
Lactobacillus
+1 more

MGM Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Donor milkActive Control1 Intervention
Pasteurized donor breast milk
Group II: Preterm infant formulaPlacebo Group1 Intervention
Preterm formula determined by clinical practice

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,497 Previous Clinical Trials
11,935,641 Total Patients Enrolled
University of California, DavisOTHER
909 Previous Clinical Trials
4,704,082 Total Patients Enrolled
Valerie Flaherman, MD, MPHPrincipal InvestigatorUniversity of California, San Francisco
5 Previous Clinical Trials
4,115 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Which demographic is eligible to partake in this clinical trial?

"This research is looking for late preterm newborns between 34 and 37 weeks gestation, who have breast milk intolerance and are aged 1 Hour to 96 Hours. Furthermore, participants must also be those in which the clinical team plans to start supplementation."

Answered by AI

Are geriatric patients being included in this clinical research?

"According to the criteria stipulated for this clinical trial, enrollees must be between 1 Hour and 96 Hours old. Additionally, there are 395 trials available for minors and 708 for those over 65 years of age."

Answered by AI

How many participants are there in this experiment?

"Affirmative. Clinicaltrials.gov confirms that this research project is currently recruiting participants, which first began on October 30th 2017 and was most recently updated on August 2nd 2022. The trial requires 48 subjects to be enrolled at one site."

Answered by AI

Is there still capacity to enroll participants in this clinical investigation?

"That is correct. According to clinicaltrials.gov, this research study which was initially published on October 30th 2017 is actively enrolling participants. 48 volunteers need to be enrolled at one site in particular."

Answered by AI
~6 spots leftby Apr 2025